Skip to content

Electronic Medical Records and Genomics

Genetic and Electronic Medical Records to Predict Outcomes in Heart Failure Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02043431
Enrollment
1000
Registered
2014-01-23
Start date
2012-08-31
Completion date
2018-12-31
Last updated
2018-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart failure, Electronic medical records, Genomics, Biobank

Brief summary

The purpose of this study is to develop a biobank containing samples of 2,000 patients treated in a tertiary cardiology hospital containing electronic medical records and genetic data in genome-wide scale for performing genetic association studies for validation and development of medical decision routines that help the clinical management of heart failure patients.

Detailed description

Patients between 18 and 80 years old with heart failure diagnosis of different etiologies and left ventricular ejection fraction \< 50% in the past 2 years will be eligible for enrollment on the cohort. After consent, patients will be submitted to clinical baseline, echocardiographic, cardiography impedance and biochemical evaluation. Study data will be collected and managed using Research Electronic Data Capture (REDCap) tools. The follow up will take place every 6 months to assess cardiovascular outcomes (all-cause mortality, cardiovascular mortality, hospitalization for worsening heart failure and current medication use). Initial analytical strategy will focus on the establishment of the accuracy of electronic medical records extraction protocols for main predictor factors of morbidity and mortality in heart failure.

Interventions

None listed

Sponsors

Ministry of Health, Brazil
CollaboratorOTHER_GOV
University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 80 years old * Heart failure diagnosis of different etiologies * Left ventricular ejection fraction \< 50% in the past 2 years

Exclusion criteria

* Patients with impaired cognition due to advanced dementia syndrome or severe psychiatric disorder * Patients without telephone access * Patients that refused to participate

Design outcomes

Primary

MeasureTime frameDescription
all cause mortalitysix and twelve months after inclusion.Deaths for all causes after 6 months of inclusion. Deaths for all causes after 12 months of inclusion

Secondary

MeasureTime frameDescription
cardiovascular mortalitysix and twelve months after inclusion.Deaths for cardiovascular cause after 6 months of inclusion. Deaths for cardiovascular cause after 12 months of inclusion.

Other

MeasureTime frameDescription
Hospitalization for any causesix and twelve months after inclusion.necessity of hospital care in 6 and 12 months of follow-up

Countries

Brazil

Contacts

Primary ContactAlexandre C Pereira, MD, PhD
alexandre.pereira@incor.usp.br55-11-2661-5543
Backup ContactLuciana Gioli-Pereira, MD, PhD
lu_gioli@yahoo.com55-11-2661-5081

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026